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Abstract
Fluid management strategies need to be guided by an understanding of the
pathophysiologic mechanisms underlying fluid imbalance. In the hypovolaemic patient,
reduced circulating blood volume and venous return and, in severe cases, altered tissue
perfusion may initiate a cascade of pathophysiologic processes culminating in multiple organ
failure. The objectives of fluid management are to maintain adequate blood pressure, tissue
oxygenation and intravascular fluid volume. Both crystalloids and colloids can be useful for
these purposes. In the hypovolaemic patient with normal pulmonary function, the use of
colloids to maintain colloid osmotic pressure can limit the development of peripheral as well
as pulmonary oedema. However, choice of fluid is less important in states of increased lung
capillary permeability. Further evidence is needed to broaden understanding of the optimal
roles for particular fluid management strategies. Experimental models can make an important
contribution in gathering such evidence. Rigorous pharmacoeconomic studies are also
needed to define the benefits and costs of differing fluid regimens.
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ALI = acute lung injury; ARDS = acute respiratory distress syndrome; ICU = intensive care unit.
http://ccforum.com/content/4/S2/S1
Most critically ill patients will require volume expansion at
some juncture during their stay in the intensive care unit
(ICU). Common indications for fluid administration in the
ICU include trauma, haemorrhage, dehydration and sepsis.
Surgical patients also typically require fluids both peri-
operatively and postoperatively. An array of additional
clinical situations may also prompt fluid administration; for
instance, in burn victims, hypoproteinaemic patients,
cirrhotic patients with ascites undergoing therapeutic para-
centesis, and so on.
The pathophysiologic mechanisms of fluid imbalance and
the optimal approaches to fluid management continue to be
actively investigated in both clinical and preclinical studies.
Further light is also being shed on fluid management issues
by recent meta-analyses. The meta-analytic findings are
provocative; however, many questions have been raised
regarding their implications for clinical practice. One such
question is the appropriateness of relying on mortality as the
primary outcome measure, since choice of fluid may exert a
relatively minor impact on this particular endpoint. Also, the
manner in which the skilled clinician implements a fluid man-
agement strategy may have a greater bearing on outcome
than the type of fluid administered.
The appropriate basis for adopting a particular fluid man-
agement strategy is an understanding of the underlying
pathophysiology of fluid imbalance. Hypovolaemia canCritical Care    Vol 4 Suppl 2 Vincent
lead to reduced circulating blood volume, diminished
venous return and, in severe cases, arterial hypotension.
The aims of fluid management are to preserve intravascu-
lar fluid volume, adequate blood pressure and tissue oxy-
genation. In the hypovolaemic patient with normal
pulmonary function, the use of colloids to maintain colloid
osmotic pressure can limit the development of pulmonary
oedema under conditions of elevated hydrostatic pres-
sure. This approach may be of more limited value during
states of increased lung capillary permeability; however,
since the permeability barrier generally remains at least
partially intact, colloid administration may still be useful.
There is growing appreciation that hypovolaemia may also
precipitate localized microcirculatory disorders, in which
tissue perfusion is locally compromised despite apparent
systemic normovolaemia. Severe hypovolaemia may ulti-
mately lead to multiple organ failure.
The appropriate roles for colloids and crystalloids continue
to be a major focus of clinical investigation. These two
fluid categories appear to be largely indistinguishable in
terms of their effects on preload recruitable stroke volume
or oxygen delivery. However, because of their propensity
for leakage into the extravascular space, crystalloids need
to be administered in volumes approximately three-fold
greater than those of colloids in order to achieve compara-
ble resuscitation endpoints. Colloids, in contrast, are
retained to a greater degree in the intravascular space,
and hence smaller infused volumes are needed to attain
haemodynamic endpoints. Based on limited data, colloids
may offer the advantage of enhancing oxygen consump-
tion to a greater extent than crystalloids. Crystalloids are
generally regarded as first-line fluids for the haemodynami-
cally stable patient and, in the typical scenario, colloids are
administered in addition to rather than in lieu of crystal-
loids. However, when the patient is haemodynamically
compromised, colloids are preferred by many clinicians
including authorities in the field of critical care medicine.
The comparative advantages and limitations of natural and
artificial colloids are also a topic of contention. Advantages
of the natural colloid albumin vis-à-vis artificial colloids
include a less limited recommended dose range, reduced
risk of haemostatic complications, clearance without tissue
deposition, and lower incidence of anaphylactoid reactions.
Albumin is also readily monitored on a routine basis, so that
there is diminished potential for excessive administration of
this colloid and consequent hyperalbuminaemia, although
this risk is remote. Artificial colloids are less expensive per
unit dose and have not been subject to the same periodic
supply shortages as albumin.
Clinical investigations into the pathophysiology of fluid
imbalance have become increasingly sophisticated with the
availability of monitoring tools such as intrathoracic blood
volume measurement, mercury plethysmography and labelled
erythrocytes, plasma or albumin. Nevertheless, an important
role remains to be played by experimental models. There
are, of course, limitations in the use of animal models. Suit-
able models of multiple organ failure and of acute respira-
tory distress syndrome (ARDS), for example, have proven
elusive. Nevertheless, many models are available that can
potentially reproduce a particular state of fluid imbalance
and allow the effects of therapeutic interventions to be
meaningfully assessed. Animal models can aid in the justifi-
cation and design of clinical trials and are also well suited
for investigating pathophysiologic mechanisms.
Intriguing new clinical data are now emerging in the area of
acute lung injury (ALI) and ARDS. It is well established that
hydrostatic pressure can contribute to ALI and ARDS.
Transit of large molecules into the interstitial space may be
increased due to capillary leakage in these inflammatory
conditions. Nonetheless, the permeability barrier to large
molecules is usually not entirely abolished, and therefore
osmotic pressure may also play a role. A preliminary report
has appeared describing the results of a randomized con-
trolled trial employing combination therapy with albumin and
furosemide in ALI patients. This therapy increased serum
albumin and total serum protein levels, promoted weight
loss, increased acute oxygenation and improved long-term
haemodynamic stability without clinically important adverse
effects. If these observations are confirmed in larger-scale
trials, this fluid management approach could potentially
provide a welcome option for these high-risk patients.
Although cost has long been a major concern in fluid man-
agement, the available data on which to base clinical deci-
sions are highly limited. Most studies reported to date
have focused exclusively on cost differences between
administered fluids. Rigorous pharmacoeconomic data are
needed that address the comparative total costs of care
between different fluid management regimens in particular
clinical indications. Specifically, the costs incurred as a
result of fluid-associated morbidity, mortality and differ-
ences in length of ICU or hospital stay also need to be
taken into account.
The optimal types of fluids and administration regimens for
particular indications remain far from resolved. Fluid
management controversies are long standing, especially
concerning the comparative merits of colloids and crystal-
loids. Nevertheless, numerous studies are continuing to
elucidate further the effectiveness and safety of differing
fluid management approaches. As a consequence, this
area of investigation remains vibrant.
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